{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:23:10Z","timestamp":1791084190321,"version":"4.1.0"},"reference-count":43,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019230","name":"Wuhan Union Hospital","doi-asserted-by":"publisher","award":["Scientific Research Training Program for Young Tal"],"award-info":[{"award-number":["Scientific Research Training Program for Young Tal"]}],"id":[{"id":"10.13039\/501100019230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SIRIC","award":["CARPEM"],"award-info":[{"award-number":["CARPEM"]}]},{"name":"SIRIC","award":["SOCRATE"],"award-info":[{"award-number":["SOCRATE"]}]},{"DOI":"10.13039\/501100006431","name":"Canc\u00e9rop\u00f4le Ile-de-France","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006431","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015545","name":"Seerave Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","award":["ASPIRE"],"award-info":[{"award-number":["ASPIRE"]}],"id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AMMICa","award":["US23\/CNRS UMS3655"],"award-info":[{"award-number":["US23\/CNRS UMS3655"]}]},{"DOI":"10.13039\/501100004795","name":"Institut Universitaire de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["Equipex Onco-Pheno-Screen"],"award-info":[{"award-number":["Equipex Onco-Pheno-Screen"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["Projets blancs"],"award-info":[{"award-number":["Projets blancs"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["RHU Immunolife"],"award-info":[{"award-number":["RHU Immunolife"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ile de france","award":["DIM ELICIT"],"award-info":[{"award-number":["DIM ELICIT"]}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["Crimson"],"award-info":[{"award-number":["Crimson"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["Oncobiome"],"award-info":[{"award-number":["Oncobiome"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["Prevalung"],"award-info":[{"award-number":["Prevalung"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018872","name":"Labex Immuno-Oncology","doi-asserted-by":"publisher","award":["ANR-18-IDEX-0001"],"award-info":[{"award-number":["ANR-18-IDEX-0001"]}],"id":[{"id":"10.13039\/501100018872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PLBIO21-115"],"award-info":[{"award-number":["PLBIO21-115"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PLBIO22-101"],"award-info":[{"award-number":["PLBIO22-101"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 de Paris","doi-asserted-by":"publisher","award":["ANR-18-IDEX-0001"],"award-info":[{"award-number":["ANR-18-IDEX-0001"]}],"id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ELIOR"},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Joint Programme on Rare Diseases"},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101052444"],"award-info":[{"award-number":["101052444"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2021-ADG"],"award-info":[{"award-number":["ERC-2021-ADG"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lique contre le cancer"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2023,6,21]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Most immunotherapies approved for clinical use rely on the use of recombinant proteins and cell-based approaches, rendering their manufacturing expensive and logistics onerous. The identification of novel small molecule immunotherapeutic agents might overcome such limitations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>For immunopharmacological screening campaigns, we built an artificial miniature immune system in which dendritic cells (DCs) derived from immature precursors present MHC (major histocompatibility complex) class I-restricted antigen to a T-cell hybridoma that then secretes interleukin-2 (IL-2).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The screening of three drug libraries relevant to known signaling pathways, FDA (Food and Drug Administration)-approved drugs and neuroendocrine factors yielded two major hits, astemizole and ikarugamycin. Mechanistically, ikarugamycin turned out to act on DCs to inhibit hexokinase 2, hence stimulating their antigen presenting potential. In contrast, astemizole acts as a histamine H1 receptor (H1R1) antagonist to activate T cells in a non-specific, DC-independent fashion. Astemizole induced the production of IL-2 and interferon-\u03b3 (IFN-\u03b3) by CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells both in vitro and in vivo. Both ikarugamycin and astemizole improved the anticancer activity of the immunogenic chemotherapeutic agent oxaliplatin in a T cell-dependent fashion. Of note, astemizole enhanced the CD8<jats:sup>+<\/jats:sup>\/Foxp3<jats:sup>+<\/jats:sup> ratio in the tumor immune infiltrate as well as IFN-\u03b3 production by local CD8<jats:sup>+<\/jats:sup> T lymphocytes. In patients with cancer, high H1R1 expression correlated with low infiltration by TH1 cells, as well as with signs of T-cell exhaustion. The combination of astemizole and oxaliplatin was able to cure the majority of mice bearing orthotopic non-small cell lung cancers (NSCLC), then inducing a state of protective long-term immune memory. The NSCLC-eradicating effect of astemizole plus oxaliplatin was lost on depletion of either CD4<jats:sup>+<\/jats:sup> or CD8<jats:sup>+<\/jats:sup> T cells, as well as on neutralization of IFN-\u03b3.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings underscore the potential utility of this screening system for the identification of immunostimulatory drugs with anticancer effects.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2023-006785","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T02:00:26Z","timestamp":1688695226000},"page":"e006785","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses"],"prefix":"10.1136","volume":"11","author":[{"given":"Shuai","family":"Zhang","sequence":"first","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"},{"name":"Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Paris Saclay, Kremlin Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijing","family":"Li","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Paris Saclay, Kremlin Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5554-2075","authenticated-orcid":false,"given":"Wei","family":"Xie","sequence":"additional","affiliation":[{"name":"Cell death and Inflammation Unit, VIB-UGent Center for Inflammation Research, Ghent, Belgium"},{"name":"Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ling","family":"Tian","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-7562","authenticated-orcid":false,"given":"Jonathan G","family":"Pol","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1260-8617","authenticated-orcid":false,"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Paris Saclay, Kremlin Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Paris Saclay, Kremlin Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Mao","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 de Paris Saclay, Kremlin Bic\u00eatre, France"},{"name":"Surgical Oncology Department, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[{"name":"INSERM U1015, Equipe labellis\u00e9e par la Ligue contre le cancer, Gustave Roussy, Villjuif, France"},{"name":"ClinicObiome, Gustave-Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2409-7073","authenticated-orcid":false,"given":"Yang","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-9558","authenticated-orcid":false,"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"},{"name":"Centre de Recherche des Cordeliers, Equipe labellis\u00e9e par la Ligue contre le cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, Paris, France"},{"name":"Institut du Cancer Paris CARPEM, Department of Biology, H\u00f4pital Europ\u00e9en Georges Pompidou, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"2025100310175945000_11.7.e006785.1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050915"},{"key":"2025100310175945000_11.7.e006785.2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1523"},{"key":"2025100310175945000_11.7.e006785.3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402201"},{"key":"2025100310175945000_11.7.e006785.4","doi-asserted-by":"publisher","DOI":"10.1038\/nm1622"},{"key":"2025100310175945000_11.7.e006785.5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35180"},{"key":"2025100310175945000_11.7.e006785.6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune Checkpoint inhibitors","volume":"17","author":"Galluzzi","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025100310175945000_11.7.e006785.7","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2998"},{"key":"2025100310175945000_11.7.e006785.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.03.030"},{"key":"2025100310175945000_11.7.e006785.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.001"},{"key":"2025100310175945000_11.7.e006785.10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-073118-011031"},{"key":"2025100310175945000_11.7.e006785.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-022-00393-8","article-title":"Author correction: the foundations of immune Checkpoint blockade and the Ipilimumab approval Decennial","volume":"21","author":"Korman","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2025100310175945000_11.7.e006785.12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat Immunol"},{"key":"2025100310175945000_11.7.e006785.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01765-8"},{"key":"2025100310175945000_11.7.e006785.14","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1795995","article-title":"Lurbinectedin: an FDA-approved inducer of Immunogenic cell death for the treatment of small-cell lung cancer","volume":"9","author":"Kepp","year":"2020","journal-title":"Oncoimmunology"},{"key":"2025100310175945000_11.7.e006785.15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s41573-022-00538-9","article-title":"The expanding role for small molecules in Immuno-oncology","volume":"21","author":"Offringa","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2025100310175945000_11.7.e006785.16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0465"},{"key":"2025100310175945000_11.7.e006785.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100732","article-title":"A genotype-phenotype screening system using conditionally immortalized immature Dendritic cells","volume":"2","author":"Zhao","year":"2021","journal-title":"STAR Protoc"},{"key":"2025100310175945000_11.7.e006785.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062621","article-title":"Generation of inducible immortalized Dendritic cells with proper immune function in vitro and in vivo","volume":"8","author":"Richter","year":"2013","journal-title":"PLoS One"},{"key":"2025100310175945000_11.7.e006785.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.13.6020"},{"key":"2025100310175945000_11.7.e006785.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02332-3"},{"key":"2025100310175945000_11.7.e006785.21","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1096\/fj.201901237R","article-title":"Ikarugamycin inhibits Pancreatic cancer cell Glycolysis by targeting Hexokinase 2","volume":"34","author":"Jiang","year":"2020","journal-title":"FASEB J"},{"key":"2025100310175945000_11.7.e006785.22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2165\/00003495-198427030-00003","article-title":"A review of its pharmacodynamic properties and therapeutic efficacy","volume":"27","author":"Richards","year":"1984","journal-title":"Drugs"},{"key":"2025100310175945000_11.7.e006785.23","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.200409041"},{"key":"2025100310175945000_11.7.e006785.24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002155","article-title":"Modulation of lactate-Lysosome axis in Dendritic cells by Clotrimazole potentiates antitumor immunity","volume":"9","author":"Wang","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2025100310175945000_11.7.e006785.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80702-3"},{"key":"2025100310175945000_11.7.e006785.26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.497"},{"key":"2025100310175945000_11.7.e006785.27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cpdd.236","article-title":"Perspectives in drug development and clinical pharmacology: the discovery of histamine H1 and H2 antagonists","volume":"5","author":"Jones","year":"2016","journal-title":"Clin Pharmacol Drug Dev"},{"key":"2025100310175945000_11.7.e006785.28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccell.2021.11.002","article-title":"The allergy mediator histamine confers resistance to Immunotherapy in cancer patients via activation of the macrophage histamine receptor H1","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"2025100310175945000_11.7.e006785.29","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/jnci\/djz217","article-title":"Antihistamines and ovarian cancer survival: nationwide cohort study and in vitro cell viability assay","volume":"112","author":"Verdoodt","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"2025100310175945000_11.7.e006785.30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ebiom.2016.06.013","article-title":"Repurposing Cationic Amphiphilic Antihistamines for cancer treatment","volume":"9","author":"Ellegaard","year":"2016","journal-title":"EBioMedicine"},{"key":"2025100310175945000_11.7.e006785.31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.07.006","article-title":"Efficacy of Cationic Amphiphilic Antihistamines on outcomes of patients treated with immune Checkpoint inhibitors","volume":"174","author":"Chiang","year":"2022","journal-title":"Eur J Cancer"},{"key":"2025100310175945000_11.7.e006785.32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau2001","article-title":"Biophysical basis underlying dynamic Lck activation visualized by Zaplck FRET Biosensor","volume":"5","author":"Wan","year":"2019","journal-title":"Sci Adv"},{"key":"2025100310175945000_11.7.e006785.33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-0716-1278-1_16","article-title":"In vivo imaging of orthotopic lung cancer models in mice","volume":"2279","author":"Liu","year":"2021","journal-title":"Methods Mol Biol"},{"key":"2025100310175945000_11.7.e006785.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(02)00013-3"},{"key":"2025100310175945000_11.7.e006785.35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jim.2015.01.004","article-title":"A reproducible method for the expansion of Mouse Cd8+ T lymphocytes","volume":"417","author":"Lewis","year":"2015","journal-title":"J Immunol Methods"},{"key":"2025100310175945000_11.7.e006785.36","doi-asserted-by":"crossref","unstructured":"Ghosh M , Shapiro LH . In vitro AG cross-presentation and in vivo AG cross-presentation by Dendritic cells in the Mouse. BIO-PROTOCOL 2012;2. doi:10.21769\/BioProtoc.305","DOI":"10.21769\/BioProtoc.305"},{"key":"2025100310175945000_11.7.e006785.37","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911622","article-title":"Inhibition of transcription by Dactinomycin reveals a new characteristic of Immunogenic cell stress","volume":"12","author":"Humeau","year":"2020","journal-title":"EMBO Mol Med"},{"key":"2025100310175945000_11.7.e006785.38","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: Digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"2025100310175945000_11.7.e006785.39","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa407"},{"key":"2025100310175945000_11.7.e006785.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.09.006"},{"key":"2025100310175945000_11.7.e006785.41","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118"},{"key":"2025100310175945000_11.7.e006785.42","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-Seq data with Deseq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025100310175945000_11.7.e006785.43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2023-006785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:18:12Z","timestamp":1759511892000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2023-006785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,6]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/jitc-2023-006785"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2023-006785","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]}}}